Efficacy and Safety Study of Beclometasone/Formoterol Single Inhaler in Patients With COPD

NCT00476099 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

828

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease

Interventions

DRUG: Beclomethasone 100 µg plus formoterol 6 µg (CHF1535) pMDI
DRUG: Budesonide 200 µg plus formoterol 6 µg DPI
DRUG: Formoterol 12 µg DPI

Sponsor

Chiesi Farmaceutici S.p.A.